Medtronic market cap is $174.1 b, and annual revenue was $28.91 b in FY 2020

Medtronic Gross profit (Q3, 2021)5.2 B

Medtronic Gross profit margin (Q3, 2021), %66.3%

Medtronic Net income (Q3, 2021)1.3 B

Medtronic EBIT (Q3, 2021)1.3 B

Medtronic Cash, 29-Jan-20215.1 B

Medtronic EV199.4 B

Medtronic revenue was $28.91 b in FY, 2020 which is a 5.4% year over year decrease from the previous period.

Medtronic revenue breakdown by business segment: 8.2% from Diabetes Group, 28.9% from Minimally Invasive Therapies Group, 36.2% from Cardiac and Vascular Group and 26.7% from Restorative Therapies Group

Medtronic revenue breakdown by geographic segment: 51.6% from United States, 32.1% from Non-U.S. Developed Markets and 16.3% from Emerging Markets

USD | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|

## Revenue | 30.0b | 30.6b | 28.9b |

| 1% | 2% | (5%) |

## Cost of goods sold | 9.1b | 9.2b | 9.4b |

## Gross profit | 20.9b | 21.4b | 19.5b |

| 70% | 70% | 67% |

## R&D expense | 2.3b | 2.3b | 2.3b |

## General and administrative expense | 10.0b | 10.4b | 10.1b |

## Operating expense total | 12.4b | 15.1b | 14.7b |

## Depreciation and amortization | 1.8b | 1.8b | 1.8b |

## EBIT | 6.7b | 6.3b | 4.8b |

| 22% | 21% | 17% |

## Interest expense | 1.1b | 1.4b | 1.1b |

## Interest income | 397.0m | ||

## Pre tax profit | 5.7b | 5.2b | 4.1b |

## Income tax expense | 2.6b | 547.0m | (751.0m) |

## Net Income | 3.1b | 4.7b | 4.8b |

## EPS | 2.3 | 3.4 | 3.5 |

USD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 |
---|---|---|---|---|---|---|---|---|---|

## Revenue | 7.4b | 7.5b | 7.5b | 7.5b | 7.7b | 7.7b | 6.5b | 7.6b | 7.8b |

## Cost of goods sold | 2.2b | 2.2b | 2.3b | 2.4b | 2.4b | 2.4b | 2.5b | 2.7b | 2.6b |

## Gross profit | 5.2b | 5.3b | 5.3b | 5.1b | 5.3b | 5.3b | 4.0b | 4.9b | 5.2b |

| 70% | 71% | 70% | 68% | 69% | 69% | 62% | 65% | 66% |

## R&D expense | 585.0m | 590.0m | 561.0m | 587.0m | 603.0m | 573.0m | 621.0m | 639.0m | 601.0m |

## General and administrative expense | 2.6b | 2.6b | 2.6b | 2.5b | 2.6b | 2.6b | 2.4b | 2.6b | 2.5b |

## Operating expense total | 3.5b | 3.3b | 3.3b | 3.6b | 4.0b | 3.7b | 3.3b | 4.0b | 3.9b |

## Depreciation and amortization | 446.0m | 445.0m | 436.0m | 440.0m | 441.0m | 436.0m | 440.0m | 443.0m | 453.0m |

## EBIT | 1.2b | 1.5b | 1.5b | 1.5b | 1.4b | 1.6b | 673.0m | 930.0m | 1.3b |

| 17% | 21% | 20% | 20% | 18% | 21% | 10% | 12% | 16% |

## Interest expense | 242.0m | 241.0m | 243.0m | 609.0m | 165.0m | 156.0m | 171.0m | 470.0m | 143.0m |

## Pre tax profit | 1.2b | 1.4b | 1.4b | 977.0m | 1.3b | 1.6b | 584.0m | 525.0m | 1.2b |

## Income tax expense | 103.0m | 235.0m | 99.0m | 100.0m | (77.0m) | (340.0m) | 93.0m | 31.0m | (59.0m) |

## Net Income | 1.1b | 1.1b | 1.3b | 877.0m | 1.4b | 1.9b | 491.0m | 494.0m | 1.3b |

## EPS | 0.8 | 0.8 | 0.9 | 0.6 | 1.0 | 1.4 | 0.4 | 0.4 | 0.9 |

USD | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|

## Cash | 3.7b | 4.4b | 4.1b |

## Accounts Receivable | 6.0b | 6.2b | 4.6b |

## Inventories | 3.6b | 3.8b | 4.2b |

## Current Assets | 23.0b | 22.0b | 22.0b |

## PP&E | 4.6b | 4.7b | 4.8b |

## Goodwill | 39.5b | 40.0b | 39.8b |

## Total Assets | 91.4b | 89.7b | 90.7b |

## Accounts Payable | 1.6b | 2.0b | 2.0b |

## Short-term debt | 2.1b | 838.0m | 2.8b |

## Current Liabilities | 10.1b | 8.5b | 10.4b |

## Long-term debt | 23.7b | 24.5b | 22.0b |

## Total Debt | 25.8b | 25.3b | 24.8b |

## Total Liabilities | 40.6b | 39.5b | 39.8b |

## Additional Paid-in Capital | 28.1b | 26.5b | 26.2b |

## Retained Earnings | 24.4b | 26.3b | 28.1b |

## Total Equity | 50.8b | 50.2b | 50.9b |

## Debt to Equity Ratio | 0.5 x | 0.5 x | 0.5 x |

## Debt to Assets Ratio | 0.3 x | 0.3 x | 0.3 x |

## Financial Leverage | 1.8 x | 1.8 x | 1.8 x |

USD | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|

## Net Income | 3.1b | 4.7b | 4.8b |

## Depreciation and Amortization | 2.6b | 2.7b | 2.7b |

## Accounts Receivable | (275.0m) | (581.0m) | 1.3b |

## Inventories | (192.0m) | (274.0m) | (577.0m) |

## Accounts Payable | 65.0m | 399.0m | (44.0m) |

## Cash From Operating Activities | 4.7b | 7.0b | 7.2b |

## Purchases of PP&E | (1.1b) | (1.1b) | (1.2b) |

## Cash From Investing Activities | 5.9b | (774.0m) | (3.2b) |

## Short-term Borrowings | (294.0m) | (713.0m) | (17.0m) |

## Long-term Borrowings | (7.4b) | (7.9b) | (6.1b) |

## Dividends Paid | (2.5b) | (2.7b) | (2.9b) |

## Cash From Financing Activities | (12.0b) | (5.4b) | (4.2b) |

## Net Change in Cash | (1.3b) | 724.0m | (253.0m) |

## Interest Paid | 1.1b | 973.0m | 643.0m |

## Income Taxes Paid | 2.5b | 1.6b | 878.0m |

USD | FY, 2018 |
---|---|

## EV/EBIT | 19.9 x |

## EV/CFO | 28.2 x |

## Revenue/Employee | 346.8k |

## Debt/Equity | 0.5 x |

## Debt/Assets | 0.3 x |

## Financial Leverage | 1.8 x |

## P/E Ratio | 35.8 |

FY, 2018 | |
---|---|

## Сorporate Сontributions | $54.9 m |

## Water Used | 2.2 m cubic meters |

## Volunteers | 20.95 k |

## Volunteer Hours | 58.54 k |

## Total Greenhouse Gas Emissions | 299 k metric tons of carbon dioxide equivalent |

## Products Donated in Cash Equivalent | $15.4 m |

## Nonhazardous Waste Generated | 22.27 k metric tons |

## Hazardous Waste Generated | 3.1 k metric tons |

## Energy Used | 908.87 k MWh |

FY, 2019 | FY, 2018 | FY, 2017 | FY, 2016 | FY, 2015 | FY, 2014 | |
---|---|---|---|---|---|---|

Female, percent | 50% | 50% | 49% | 49% | 48% | 49% |

Male, percent | 50% | 50% | 51% | 51% | 52% | 51% |

FY, 2019 | FY, 2018 | FY, 2017 | |
---|---|---|---|

Male (Management), percent | 62% | 63% | 66% |

Female (Management), percent | 38% | 37% | 34% |